The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) contains a number of work programmes whose goal is to strengthen the benefit-risk monitoring of medicines in Europe. Work program 5 (Benefit-Risk group) of PROTECT has developed a new website on available methods for benefit-risk evaluation and representation. It includes supporting tools and recommendations for use of benefit-risk methodologies and intends to be a guide for readers who are new to the world of benefit-risk assessment.
Related information:
Details
- Publication date
- 1 August 2014
- Author
- European Medicines Agency